Skip to content
Screener

CeriBell, Inc. CBLL Q2 2026 earnings

Reported August 10, 2026 · After market close

Revenue$28.1MBeat by $821.3K
EPS-$0.51Miss by $0.04
Revenue estimate$27.3M
EPS estimate-$0.47
“Our second quarter results reflect adoption accelerating across both new and existing accounts, Combined with the early progress of our delirium pilot and multiple new FDA 510(k) clearances, we are highly confident in the strength of our business and our mission to establish EEG as a new vital sign.”
Management

Next report

Date not yet announced

Financials

Q2 2026

Income statement

See full
Revenue$28.1M+32.5%
Gross profit$25.9M+38.8%
Operating income-$20.0M-33.6%
Net income-$19.3M-41.2%
EPS (diluted)-$0.51-34.2%

Balance sheet

See full
Cash & equivalents$32.7M-18.6%
Total debt$21.9M+1.7%
Total equity$128.3M-25.5%
Total assets$166.3M-19.9%

Cash flow

See full
Operating cash flow-$12.9M-70.8%
CapEx$17.0K-76.1%
Free cash flow-$12.9M-69.4%

Valuation & ratios

Valuation

as of 08/11/26
See full
Market cap$732.29M+54.7%
Enterprise value$721.54M+58.7%
P/S7.2×+1.1×

Profitability

See full
Gross margin88.9%+1.1pp
Operating margin-68.6%+1.5pp
Net margin-64.7%+0.9pp
FCF margin-53.7%+4.4pp

Returns & leverage

See full
Return on equity-43.9%—
Debt / equity0.2×0.0×
Current ratio9.2×-4.1×

Segments

By product

See full
EEG Recorders And Wearables Sales Point In Time$21.2M—
EEG Portal And Clarity Subscriptions And Recorder Loans Over Time$6.9M—

FAQ

When did CeriBell, Inc. report Q2 2026 earnings?
CeriBell, Inc. (CBLL) reported Q2 2026 earnings on August 10, 2026 after market close.
What were CeriBell, Inc.'s Q2 2026 revenue and EPS?
CeriBell, Inc. reported revenue of $28.1M and eps of $-0.51 for Q2 2026.
Did CeriBell, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $27.3M by $821.3K. EPS missed the consensus estimate of $-0.47 by $0.04.
How did CeriBell, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 32.5% from $21.2M a year earlier and eps declined 34.2% from $-0.38.
Where can I find CeriBell, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-342463) and the 10-Q periodic report (0001193125-26-342574) directly on SEC EDGAR. The filing index links above go to sec.gov.